Request Demo
Recent blog posts
Latest Hotspot
8 min read
CTR20261235 LW-402 Moderate Atopic Dermatitis Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
24 August 2026
CTR20261235 clinical trial report covering LW-402, Phase 2, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07516366 Botensilimab Renal Cell Carcinoma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
24 August 2026
NCT07516366 clinical trial report covering Botensilimab, Phase 2, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07516847 Dapagliflozin Anemia Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
24 August 2026
NCT07516847 clinical trial report covering Dapagliflozin, Phase 2, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
ChiCTR2600122134 Butaselen Progressive fibrotic interstitial lung disease Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
24 August 2026
ChiCTR2600122134 clinical trial report covering Butaselen, Phase 2, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07389616 Azacitidine Peripheral T-Cell Lymphoma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
24 August 2026
NCT07389616 clinical trial report covering Azacitidine, Phase 2/3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07388680 Pirfenidone Radiation Injuries Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
24 August 2026
NCT07388680 clinical trial report covering Pirfenidone, Phase 2/3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07392866 Bevacizumab Advanced Hepatocellular Carcinoma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
24 August 2026
NCT07392866 clinical trial report covering Bevacizumab, Phase 2/3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07392892 SSGJ-707 Adenocarcinoma of Esophagus Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
24 August 2026
NCT07392892 clinical trial report covering SSGJ-707, Phase 2/3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07404397 Cyclobenzaprine hydrochloride Pelvic Floor Disorders Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
24 August 2026
NCT07404397 clinical trial report covering Cyclobenzaprine hydrochloride, Phase 2/3, endpoints, sponsor, geography, readout timing and development white sp
Latest Hotspot
8 min read
NCT07410806 Monepantel Amyotrophic Lateral Sclerosis Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
24 August 2026
NCT07410806 clinical trial report covering Monepantel, Phase 2/3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07404553 SHR-1918 Hypercholesterolemia Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
24 August 2026
NCT07404553 clinical trial report covering SHR-1918, Phase 2/3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07412470 Methylprednisolone Renal transplant rejection Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
24 August 2026
NCT07412470 clinical trial report covering Methylprednisolone, Phase 2/3, endpoints, sponsor, geography, readout timing and development white space.